Publications by authors named "Jose Karam"

Claim this Profile
U
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.
Saeed Dabestani, Nessn H Azawi, Riccardo Campi, Petrus Järvinen, Harry Nisen, Jose A Karam

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples.
Roberto Ruiz-Cordero, Qi Wang, Gayatri Kumar, Mahmut Akgul, Chad J Creighton, Jose A Karam

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Niki M Zacharias, Manuel Ozambela, Menuka Karki, Rong He, Pankaj K Chauhan, Jose A Karam

Mol Cancer Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for First-Year Recurrence in Patients With Synchronous Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy and Complete Metastasectomy.
Ali Ghasemzadeh, E Jason Abel, Jose A Karam, Philippe E Spiess, Charles C Peyton

J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank.
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, Dena Battle, Stephanie A Berg, Jose A Karam

Urol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial.
Chad Tang, Alexander D Sherry, Aaron Seo, Kieko Hara, Haesun Choi, Jose A Karam

Lancet Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends and Socioeconomic Determinants of Cytoreductive Nephrectomy Utilization for Metastatic Renal Cell Carcinoma in the USA.
Stepan M Esagian, Pavlos Msaouel, Jose A Karam, Benjamin A Gartrell, Dimitrios Makrakis

Eur Urol Focus· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Active Surveillance on Nephrometric Scores of Bosniak III and IV Renal Cysts.
Roberto Dias Machado, Leonardo Bernardes De Amaro, Alessandro Prudente, Eliney Ferreira Faria, Antonio Antunes Rodrigues Júnior, Jose A Karam

Int J Gen Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS.
Yago Nieto, John F Ward, Wayne Hofstetter, David Rice, Jose A Karam

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell Carcinoma.
Mohamed E Abdelsalam, Ahmed Awad, Roland L Bassett, Thomas Lu, David Irwin, Jose A Karam

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.
Justin M Lebenthal, Panayiotis D Kontoyiannis, Andrew W Hahn, Zita D Lim, Priya Rao, Jose A Karam

Eur Urol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis of Individual Patient Data.
Dimitrios Makrakis, Pavlos Msaouel, Jose A Karam, Stepan Μ Esagian

Eur Urol Focus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma.
Tejas Jammihal, Renee Maria Saliby, Chris Labaki, Hanna Soulati, Juan Gallegos, Jose Karam

Nat Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial.
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront Versus Deferred Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-analysis.
Stepan M Esagian, Jose A Karam, Pavlos Msaouel, Dimitrios Makrakis

Eur Urol Focus· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Randomized Clinical Trial Protocol.
Brittany C Fields, Timothy E Newhook, Heather A Lillemoe, Wei Qiao, Jose A Karam

Adv Cancer Educ Qual Improv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010.
Jose Antonio Karam, Robert Uzzo, Axel Bex, William Leung, Connie Tat

Eur Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.
Talal El Zarif, Karl Semaan, Wanling Xie, Marc Eid, Martin Zarba, Jose A Karam

Eur Urol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety outcomes and immunological correlates in a prospective clinical trial of immune checkpoint therapy plus debulking surgery for patients with metastatic renal cell carcinoma.
Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, Daniel D Shapiro, Jose A Karam

Res Sq· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience.
Mohamed E Abdelsalam, Thomas Lu, Ali Baiomy, Ahmed Awad, Bruno C Odisio, Jose A Karam

Eur Radiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular heterogeneity of tight junction Claudins guides organotropic metastasis.
Xunian Zhou, Valerie S LeBleu, Eliot Fletcher-Sananikone, Jiha Kim, Jianli Dai, Jose Antonio Karam

Nat Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study.
Robert H Mbilinyi, Pavlos Msaouel, Priya Rao, Jose A Karam, Nizar M Tannir

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups.
Jose A Karam, Rituparna Bhattacharya, Adesuwa Ogbomo, Santosh Gautam, Rebekah Yu

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center Experience.
Mohamed E Abdelsalam, Nabeel Mecci, Ahmed Awad, Roland L Bassett, Bruno C Odisio, Jose A Karam

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy.
Mohamed E Abdelsalam, Tessa N Hudspeth, Laura Leonards, Samuel B Kusin, Jennifer R Buckley, Jose A Karam

Eur Urol Open Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis